Naval Daver

3.5k citations

144 papers · 1.5k · 1 hit paper · h-index 16

Impact in

Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 115
- Acute Myeloid Leukemia Research 96
- Chronic Myeloid Leukemia Treatments 44
- Multiple Myeloma Research and Treatments 17
Genetics 57
- Myeloproliferative Neoplasms: Diagnosis and Treatment 32
- Chronic Lymphocytic Leukemia Research 25

Co-authors: Farhad Ravandi (82 shared papers)Tapan M. Kadia (87 shared papers)Courtney D. DiNardo (71 shared papers)Marina Konopleva (39 shared papers)Nicholas J. Short (52 shared papers)Hagop M. Kantarjian (84 shared papers)Guillermo Garcia‐Manero (79 shared papers)Gautam Borthakur (44 shared papers)
Journals: Blood (78 papers)Journal of Clinical Oncology (28 papers)Haematologica (4 papers)HemaSphere (4 papers)Cancer Research (4 papers)
Partner nations: United States Japan Germany

In The Last Decade

Naval Daver

126 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges 2020 · 243 citations

Peers

Countries citing papers authored by Naval Daver

Since Specialization

Citations

This map shows the geographic impact of Naval Daver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naval Daver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naval Daver more than expected).

Fields of papers citing papers by Naval Daver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naval Daver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naval Daver. The network helps show where Naval Daver may publish in the future.

Co-authors

The 25 scholars most cited alongside Naval Daver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Naval Daver Line = papers co-authored together Naval Daver links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges Cancer Discovery ·Nicholas J. Short, Marina Konopleva, Tapan M. Kadia, Gautam Borthakur, Farhad Ravandi, Courtney D. DiNardo, Naval Daver Hit paper breakdown →	2020	243
2	Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study The Lancet Haematology ·Elias Jabbour, Nicholas J. Short, Farhad Ravandi, Xuelin Huang, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Naveen Pemmaraju, William G. Wierda, Guillermo Garcia‐Manero, Koji Sasaki, Jörge E. Cortes, Rebecca Garris, Joseph D. Khoury, Jeffrey L. Jorgensen, Nitin Jain, Joie Alvarez, Susan O’Brien, Hagop M. Kantarjian	2018	160
3	Hyper‐CVAD plus ponatinib versus hyper‐CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A propensity score analysis Cancer ·Koji Sasaki, Elias Jabbour, Farhad Ravandi, Nicholas J. Short, Deborah A. Thomas, Guillermo Garcia‐Manero, Naval Daver, Tapan M. Kadia, Marina Konopleva, Nitin Jain, Ghayas C. Issa, Vicki Jeanis, Haim G. Moore, Rebecca Garris, Naveen Pemmaraju, Jörge E. Cortes, Susan O’Brien, Hagop M. Kantarjian	2016	138
4	Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia Clinical Lymphoma Myeloma & Leukemia ·Rita Assi, Hagop M. Kantarjian, Nicholas J. Short, Naval Daver, Koichi Takahashi, Guillermo Garcia‐Manero, Courtney D. DiNardo, Jan A. Burger, Jörge E. Cortes, Nitin Jain, William G. Wierda, S Chamoun, Marina Konopleva, Elias Jabbour	2017	116
5	Sorafenib Combined with 5‐azacytidine in Older Patients with Untreated FLT3‐ITD Mutated Acute Myeloid Leukemia American Journal of Hematology ·Maro Ohanian, Guillermo Garcia‐Manero, Mark J. Levis, Elias Jabbour, Naval Daver, Gautam Borthakur, Tapan M. Kadia, Sherry Pierce, Jan A. Burger, Mary Ann Richie, Keyur P. Patel, Michael Andreeff, Zeev Estrov, Jörge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi	2018	94
6	The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial Blood ·Mahesh Swaminathan, Hagop M. Kantarjian, Naval Daver, Gautam Borthakur, Maro Ohanian, Tapan M. Kadia, Courtney D. DiNardo, Nitin Jain, Zeev Estrov, Alessandra Ferrajoli, Guillermo Garcia‐Manero, Marina Konopleva, Michael Andreeff, Naveen Pemmaraju, Elias Jabbour, William G. Wierda, Farhad Ravandi, Maria Rhona Pinsoy, Jörge E. Cortes	2017	58
7	Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia Cancer ·Farhad Ravandi, Jeffrey L. Jorgensen, Gautam Borthakur, Elias Jabbour, Tapan M. Kadia, Sherry Pierce, Mark Brandt, Sa Wang, Sergej Konoplev, Xuemei Wang, Xuelin Huang, Naval Daver, Courtney D. DiNardo, Michael Andreeff, Marina Konopleva, Zeev Estrov, Guillermo Garcia‐Manero, Jörge E. Cortes, Hagop M. Kantarjian	2016	56
8	The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia Leukemia ·Mansour Alfayez, Ghayas C. Issa, Keyur P. Patel, Feng Wang, Xuemei Wang, Nicholas J. Short, Jörge E. Cortes, Tapan M. Kadia, Farhad Ravandi, Sherry Pierce, Rita Assi, Guillermo Garcia‐Manero, Courtney D. DiNardo, Naval Daver, Naveen Pemmaraju, Hagop M. Kantarjian, Gautam Borthakur	2020	43
9	Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline TP53m AML patients: Phase 1b results. Journal of Clinical Oncology ·Naval Daver, Paresh Vyas, Suman Kambhampati, Monzr M. Al Malki, Richard A. Larson, Adam S. Asch, Gabriel N. Mannis, Wanxing Chai‐Ho, Tiffany Tanaka, Terrence Bradley, Deepa Jeyakumar, Eunice S. Wang, Guan Xing, Mark P. Chao, Giridharan Ramsingh, Camille Renard, Indu Lal, Joshua F. Zeidner, David A. Sallman	2022	38
10	Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells Haematologica ·Yannan Jia, Lina Han, Cassandra L. Ramage, Zhe Wang, Connie C. Weng, Lei Yang, Simona Colla, Helen Ma, Weiguo Zhang, Michael Andreeff, Naval Daver, Nitin Jain, Naveen Pemmaraju, Kapil N. Bhalla, Satu Mustjoki, Peiyi Zhang, Guangrong Zheng, Daohong Zhou, Qi Zhang, Marina Konopleva	2023	34
11	Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia American Journal of Hematology ·Aziz Nazha, Hagop M. Kantarjian, Farhad Ravandi, Xuelin Huang, Sangbum Choi, Guillermo Garcia‐Manero, Elias Jabbour, Gautam Borthakur, Tapan M. Kadia, Marina Konopleva, Jörge E. Cortes, Alessandra Ferrajoli, Steve Kornblau, Naval Daver, Naveen Pemmaraju, Michael Andreeff, Zeev Estrov, Min Du, Mark Brandt, Stefan Faderl	2013	32
12	A Clinical Study of Tomaralimab (OPN-305), a Toll-like Receptor 2 (TLR-2) Antibody, in Heavily Pre-Treated Transfusion Dependent Patients with Lower Risk Myelodysplastic Syndromes (MDS) That Have Received and Failed on Prior Hypomethylating Agent (HMA) Therapy Blood ·Guillermo Garcia‐Manero, Elias Jabbour, Marina Konopleva, Naval Daver, Gautam Borthakur, Courtney D. DiNardo, Prithviraj Bose, Parita Patel, Rami S. Komrokji, Aditi Shastri, Gail J. Roboz, Robert M. Miller, Sarah Arbe‐Barnes, Mary M. Reilly, Peter McGuirk, Tara Kearney, Brian Keogh, Hagop M. Kantarjian	2018	31
13	Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1‐mutated acute myeloid leukaemia British Journal of Haematology ·Sanam Loghavi, Courtney D. DiNardo, Ken Furudate, Koichi Takahashi, Tomoyuki Tanaka, Nicholas J. Short, Tapan M. Kadia, Marina Konopleva, Rashmi Kanagal‐Shamanna, Noushin Farnoud, Sherry Pierce, Joseph D. Khoury, Jeffrey L. Jorgensen, Keyur P. Patel, Naval Daver, Musa Yılmaz, L. Jeffrey Medeiros, Hagop M. Kantarjian, Farhad Ravandi, Sa A. Wang	2021	26
14	Efficacy of a Type I FLT3 Inhibitor, Crenolanib, with Idarubicin and High-Dose Ara-C in Multiply Relapsed/Refractory FLT3+ AML Blood ·Maro Ohanian, Hagop M. Kantarjian, Gautam Borthakur, Tapan M. Kadia, Marina Konopleva, Guillermo Garcia‐Manero, Zeev Estrov, Alessandra Ferrajoli, Koichi Takahashi, Elias Jabbour, Naval Daver, Steven M. Kornblau, William G. Wierda, Jan A. Burger, Kiran Naqvi, Christopher B. Benton, Prithviraj Bose, John R. Eckardt, Farhad Ravandi, Jörge E. Cortes	2016	22
15	Quizartinib with Decitabine +/- Venetoclax Is Highly Active in Patients (Pts) with FLT3-ITD Mutated (mut) Acute Myeloid Leukemia (AML): Clinical Report and Signaling Cytof Profiling from a Phase IB/II Trial Blood ·Musa Yılmaz, Hagop M. Kantarjian, Muharrem Müftüoğlu, Tapan M. Kadia, Marina Konopleva, Gautam Borthakur, Courtney D. DiNardo, Naveen Pemmaraju, Nicholas J. Short, Yesid Alvarado, Guillermo Montalban‐Bravo, Carissa Jurisprudencia, Allison Pike, Maro Ohanian, Elias Jabbour, Guillermo Garcia‐Manero, Vivian Ruvolo, Farhad Ravandi, Michael Andreeff, Naval Daver	2020	19
16	Magrolimab in combination with azacitidine for untreated higher-risk myelodysplastic syndromes (HR-MDS): 5F9005 phase 1b study results. Journal of Clinical Oncology ·David A. Sallman, Monzr M. Al Malki, Adam S. Asch, Eunice S. Wang, Joseph G. Jurcic, Terrence Bradley, Ian W. Flinn, Daniel A. Pollyea, Suman Kambhampati, Tiffany Tanaka, Joshua F. Zeidner, Guillermo Garcia‐Manero, Deepa Jeyakumar, Lin Gu, Anderson Tan, Mark P. Chao, Carol O’Hear, Indu Lal, Paresh Vyas, Naval Daver	2022	16
17	Phase I/II Study of Ruxolitinib (RUX) with Decitabine (DAC) in Patients with Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML): Phase I Results Blood ·Prithviraj Bose, Srđan Verstovšek, Yvonne Gasior, Nitin Jain, Elias Jabbour, Zeev Estrov, Yesid Alvarado, Courtney D. DiNardo, Naveen Pemmaraju, Steven M. Kornblau, Tapan M. Kadia, Naval Daver, Mark Brandt, Sherry Pierce, Graciela M. Nogueras‐González, Xuelin Huang, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Farhad Ravandi	2016	15
18	The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial Blood ·Waleed Abdelall, Hagop M. Kantarjian, Gautam Borthakur, Guillermo Garcia‐Manero, Keyur P. Patel, Elias Jabbour, Naval Daver, Tapan M. Kadia, Rosilyn A. Gborogen, Marina Konopleva, Farhad Ravandi, Michael Andreef, Jörge E. Cortes	2016	14
19	Cladribine Combined with Idarubicin and Ara-C (CLIA) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia Blood ·Preetesh Jain, Hagop M. Kantarjian, Farhad Ravandi, Elias Jabbour, Naval Daver, Naveen Pemmaraju, Courtney D. DiNardo, Yesid Alvarado, Nitin Jain, Gautam Borthakur, Srđan Verstovšek, Alessandra Ferrajoli, Maro Ohanian, Marina Konopleva, Kiran Naqvi, Tina Fitch, Guillermo Garcia‐Manero, Jörge E. Cortes, Zeev Estrov, Tapan M. Kadia	2016	13
20	The Combination of Quizartinib with Azacitidine or Low Dose Cytarabine Is Highly Active in Patients (Pts) with FLT3-ITD Mutated Myeloid Leukemias: Interim Report of a Phase I/II Trial Blood ·Gautam Borthakur, Hagop M. Kantarjian, Susan O’Brien, Guillermo Garcia‐Manero, Elias Jabbour, Naval Daver, Tapan M. Kadia, Rosilyn A. Gborogen, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jörge E. Cortes	2014	13

About Naval Daver

Naval Daver is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Oncology, having authored 144 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (96 papers), Chronic Myeloid Leukemia Treatments (44 papers), Acute Lymphoblastic Leukemia research (34 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (25 papers), Protein Degradation and Inhibitors (21 papers), Multiple Myeloma Research and Treatments (17 papers) and CAR-T cell therapy research (14 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (372 citations), Public Health, Environmental and Occupational Health (546 citations), Oncology (348 citations) and Molecular Biology (607 citations). Naval Daver has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Farhad Ravandi, Tapan M. Kadia, Courtney D. DiNardo, Marina Konopleva, Nicholas J. Short, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Gautam Borthakur, Jörge E. Cortes and Elias Jabbour. Their work appears in journals such as Blood, Journal of Clinical Oncology, Haematologica, HemaSphere and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Naval Daver

Impact in

Papers in i

In The Last Decade

Naval Daver

Hit Papers

Peers

Countries citing papers authored by Naval Daver

Fields of papers citing papers by Naval Daver

All Works

About Naval Daver

Explore authors with similar magnitude of impact

Papers in